|Articles|November 19, 2015

Michael J. Mauro Discusses the Diagnosis of CML

Michael J. Mauro, leader, Myeloproliferative Neoplasms Program, Memorial Sloan Kettering Cancer Center, discusses the diagnosis of chronic myeloid leukemia (CML).

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!

Related Content

How Monitoring Supports Survivorship After Cancer Treatment Care

ByDr. Elias Obeid

February 5th 2026

Dr. Suneel Kamath emphasized the growing importance of understanding biomarkers in patients with gastrointestinal cancers.

Expert Insights into Advances in Gastrointestinal Cancer Treatment

ByDr. Suneel Kamath

February 5th 2026

Biomarker-Free Relacorilant Combo Broadens Options in Ovarian Cancer

ByDr. Alexander B. Olawaiye

February 5th 2026

Pastina Bean Soup Supports Nutrition in Colorectal Cancer Care

BySpencer Feldman

February 4th 2026

World Cancer Day highlights the global impact of cancer, raising awareness, fostering unity and reminding us to support survivors and patients together: © stock.adobe.com.

Why World Cancer Day Matters to Patients and Survivors

ByFred Batchelor

February 4th 2026

Michael J. Mauro Discusses the Diagnosis of CML

Newsletter

Related Content

How Monitoring Supports Survivorship After Cancer Treatment Care

Expert Insights into Advances in Gastrointestinal Cancer Treatment

Biomarker-Free Relacorilant Combo Broadens Options in Ovarian Cancer

Pastina Bean Soup Supports Nutrition in Colorectal Cancer Care

Why World Cancer Day Matters to Patients and Survivors

Trending on CURE

FDA Updates Safety Warnings for Common Chemotherapy Drugs

KTX-1001 Elicits Responses in Some With Multiple Myeloma

FDA Removes Use Limitation for Yescarta in Primary CNS Lymphoma

New Combination Treatment Approach Studied in Pancreatic Cancer

Real-World Data with Amtagvi Show High Response Rates in Advanced Melanoma